ZD7288 hydrate
SIGMA/Z3777 - ≥98% (HPLC)
Synonym: 4-
Empirical Formula (Hill Notation): C15H20N4 · HCl · xH2O
Molecular Weight: 292.81 (anhydrous basis)
MDL Number: MFCD16879001
Linear Formula: C15H20N4 · HCl · xH2O
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white to beige |
form | powder |
InChI | 1S/C15H20N4.ClH.H2O/c1-5- |
InChI key | NCEDDDWQLCMZQG-UPONXUSQSA |
originator | AstraZeneca |
Quality Level | 100 ![]() |
SMILES string | O.Cl.CCN(c1ccccc1)C2=CC(= |
solubility | DMSO: 10 mg/mL, clear |
storage condition | desiccated |
storage temp. | 2-8°C |
Application: | ZD7288 hydrate has been used as Ih blocker to study its effect on neocortical tissue. It has been used as hyperpolarization-activat |
Biochem/physiol Actions: | Selective blocker of cation channel Ih; If blocker and sino-atrial node function modulator, blocks hyperpolarization-activat |
Biochem/physiol Actions: | ZD7288 can block hippocampal synaptic plasticity. |
Features and Benefits: | This compound is a featured product for Cyclic Nucleotide research. Click here ![]() ![]() |
Features and Benefits: | This compound is featured on the Cyclic Nucleotide-Gated (CNG) and Hyperpolarization Activated Cyclic Nucleotide-Gated (HCN) Channels ![]() ![]() |
Features and Benefits: | This compound was developed by AstraZeneca ![]() ![]() |
Packaging: | 5, 25 mg in glass bottle |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |